BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3468422)

  • 21. Screening the hard to reach: improving morbidity and mortality from cervical cancer in New Zealand.
    Sykes P; Sadler L; Priest P
    N Z Med J; 2008 Jul; 121(1277):5-7. PubMed ID: 18677325
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cost-benefit of expanding cervical cancer screening].
    Deng J; Tan H; Yang T; Huang X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):470-5. PubMed ID: 20543471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Present status of cytological screening for cervix neoplasms].
    Naujoks H
    Gynakologe; 1981 Dec; 14(4):204-11. PubMed ID: 6797874
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
    Hutchinson ML; Berger BM; Farber FL
    Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economics of screening for cancer of the cervix.
    Bethwaite J; Bethwaite P; Rayner T
    N Z Med J; 1986 Dec; 99(815):961. PubMed ID: 3468437
    [No Abstract]   [Full Text] [Related]  

  • 29. Economics of screening for cancer of cervix.
    Bethwaite P
    N Z Med J; 1987 Apr; 100(821):224. PubMed ID: 3455488
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiologists and cervical screening.
    Cox B
    N Z Med J; 1987 Sep; 100(832):603-4. PubMed ID: 3452105
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
    Curran DR; Stigleman S; Neher JO
    J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
    [No Abstract]   [Full Text] [Related]  

  • 32. Encouraging and reminding women to have cervical smears.
    Chang AR
    N Z Med J; 1989 Sep; 102(875):482. PubMed ID: 2779911
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E; Le Galès C; Cochand-Priollet B; Cartier I; de Crémoux P; Vacher-Lavenu MC; Vielh P; Coste J
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 35. Health insurance and cancer screening among women.
    Makuc DM; Freid VM; Parsons PE
    Adv Data; 1994 Aug; (254):1-12. PubMed ID: 10138738
    [No Abstract]   [Full Text] [Related]  

  • 36. [Critique of cytology as a mass-screening method].
    Pflanz M
    Fortschr Med; 1974 Mar; 92(9):351-2 passim. PubMed ID: 4819501
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer].
    Kallio M; Nieminen P; Anttila A; Hakama M
    Duodecim; 2001; 117(14):1442-6. PubMed ID: 12181953
    [No Abstract]   [Full Text] [Related]  

  • 38. Women's experiences of cervical screening.
    N Z Nurs J; 1987 Sep; 80(9):19-21. PubMed ID: 3696587
    [No Abstract]   [Full Text] [Related]  

  • 39. ["Cost-effectiveness" of cervical screening].
    Kostova P
    Akush Ginekol (Sofiia); 2007; 46(6):32-4. PubMed ID: 17974169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health insurance oversight issue brief: mandated benefits: cervical cancer screening coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-4. PubMed ID: 15726739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.